Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.
Ivy
D Dunbar
DD
University of Colorado Denver Health Sciences Center, Children's Hospital, USA. ivy.dunbar@tchden.org
Rosenzweig
Erika Berman
EB
Lemarié
Jean-Christophe
JC
Brand
Monika
M
Rosenberg
Daniel
D
Barst
Robyn J
RJ
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D002648:Child; D003240:Connective Tissue Diseases / Q000150:complications; D018450:Disease Progression; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D012189:Retrospective Studies; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan